grant

Pharmacological effects of oral L-citrulline and tetrahydrobiopterin in patients with peripheral artery disease [ 2009 - 2010 ]

Also known as: Novel treatment strategies for cardiovascular dieases

Research Grant

[Cite as http://purl.org/au-research/grants/nhmrc/545964]

Researchers: Prof Barry Mcgrath (Principal investigator) ,  Dr Kirstin Wingler Prof Harald Schmidt

Brief description Citrulline, named after citrullus vulgaris, the watermelon, is a precursor of arginine. Arginine is converted to protective nitric oxide (NO), which is decreased in cardiovascular diseases (CVD). Although arginine supplementation can increase NO availability and improve vascular function it is hampered by a low availability. In contrast, Citrulline is highly available and converted to Arginine. Therefore, this project will explore the therapeutic effects of Citrulline in patients with CVD.

Funding Amount $AUD 322,283.40

Funding Scheme NHMRC Project Grants

Notes Standard Project Grant

Click to explore relationships graph
Identifiers
Viewed: [[ro.stat.viewed]]